These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 16386655)
21. Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials. Paavonen J; Curr Med Res Opin; 2008 Jun; 24(6):1623-34. PubMed ID: 18435868 [TBL] [Abstract][Full Text] [Related]
22. Physical status of HPV types 16 and 18 in topographically different areas of genital tumours and in paired tumour-free mucosa. Badaracco G; Venuti A Int J Oncol; 2005 Jul; 27(1):161-7. PubMed ID: 15942656 [TBL] [Abstract][Full Text] [Related]
23. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. Arbyn M; Dillner J J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503 [TBL] [Abstract][Full Text] [Related]
24. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401 [TBL] [Abstract][Full Text] [Related]
25. Opportunity for catch-up HPV vaccination in young women after first delivery. Rama CH; Villa LL; Pagliusi S; Andreoli MA; Costa MC; Thomann P; Alves VA; Longatto-Filho A; Eluf-Neto J J Epidemiol Community Health; 2010 Jul; 64(7):610-5. PubMed ID: 19692713 [TBL] [Abstract][Full Text] [Related]
26. Attitudes about human papillomavirus vaccine in young women. Kahn JA; Rosenthal SL; Hamann T; Bernstein DI Int J STD AIDS; 2003 May; 14(5):300-6. PubMed ID: 12803935 [TBL] [Abstract][Full Text] [Related]
27. Vaccination against multiple HPV types. Elbasha EH; Galvani AP Math Biosci; 2005 Sep; 197(1):88-117. PubMed ID: 16095627 [TBL] [Abstract][Full Text] [Related]
28. Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer. Nonnenmacher B; Pintos J; Bozzetti MC; Mielzinska-Lohnas I; Lorincz AT; Ikuta N; Schwartsmann G; Villa LL; Schiller JT; Franco E Int J STD AIDS; 2003 Apr; 14(4):258-65. PubMed ID: 12716496 [TBL] [Abstract][Full Text] [Related]
29. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana. Firnhaber C; Evans D; Friedman-Khalili R; Willliams S; Michelow P; Matlhagela K; Wester C; Grinsztejn B; Lockman S J Clin Virol; 2011 Nov; 52(3):265-8. PubMed ID: 21908233 [TBL] [Abstract][Full Text] [Related]
30. Season, sun, sex, and cervical cancer. Hrushesky WJ; Sothern RB; Rietveld WJ; Du Quiton J; Boon ME Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1940-7. PubMed ID: 16103441 [TBL] [Abstract][Full Text] [Related]
31. Association of tumor necrosis factor a-2 and a-8 microsatellite alleles with human papillomavirus and squamous intraepithelial lesions among women in Brazil. Simões RT; Gonçalves MA; Donadi EA; Simões AL; Bettini JS; Duarte G; Quintana SM; Carvalho MW; Soares EG J Clin Microbiol; 2005 Aug; 43(8):3932-7. PubMed ID: 16081933 [TBL] [Abstract][Full Text] [Related]
32. Immune responses to human papillomavirus in genital tract of women with cervical cancer. Nguyen HH; Broker TR; Chow LT; Alvarez RD; Vu HL; Andrasi J; Brewer LR; Jin G; Mestecky J Gynecol Oncol; 2005 Feb; 96(2):452-61. PubMed ID: 15661235 [TBL] [Abstract][Full Text] [Related]
33. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Pastrana DV; Buck CB; Pang YY; Thompson CD; Castle PE; FitzGerald PC; Krüger Kjaer S; Lowy DR; Schiller JT Virology; 2004 Apr; 321(2):205-16. PubMed ID: 15051381 [TBL] [Abstract][Full Text] [Related]
34. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Ferber MJ; Thorland EC; Brink AA; Rapp AK; Phillips LA; McGovern R; Gostout BS; Cheung TH; Chung TK; Fu WY; Smith DI Oncogene; 2003 Oct; 22(46):7233-42. PubMed ID: 14562053 [TBL] [Abstract][Full Text] [Related]
35. Low levels of serum vitamins A and E in blood and subsequent risk for cervical cancer: interaction with HPV seropositivity. Lehtinen M; Luostarinen T; Youngman LD; Anttila T; Dillner J; Hakulinen T; Koskela P; Lenner P; Hallmans G Nutr Cancer; 1999; 34(2):229-34. PubMed ID: 10578492 [TBL] [Abstract][Full Text] [Related]
36. Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes. Palmroth J; Namujju P; Simen-Kapeu A; Kataja V; Surcel HM; Tuppurainen M; Yliskoski M; Syrjänen K; Lehtinen M Scand J Infect Dis; 2010 May; 42(5):379-84. PubMed ID: 20121650 [TBL] [Abstract][Full Text] [Related]
37. The role of viral integration in the development of cervical cancer. Yu T; Ferber MJ; Cheung TH; Chung TK; Wong YF; Smith DI Cancer Genet Cytogenet; 2005 Apr; 158(1):27-34. PubMed ID: 15771901 [TBL] [Abstract][Full Text] [Related]
38. Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Andersson-Ellström A; Dillner J; Hagmar B; Schiller J; Sapp M; Forssman L; Milsom I Sex Transm Dis; 1996; 23(3):234-8. PubMed ID: 8724515 [TBL] [Abstract][Full Text] [Related]
39. [Meta analysis of relationship between laryngeal tumor of chinese and human papillomavirus infection]. Chai LP; Su ZZ; Lei WB; Liang WY Ai Zheng; 2004 Nov; 23(11 Suppl):1400-4. PubMed ID: 15566644 [TBL] [Abstract][Full Text] [Related]
40. Order of HPV/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study. Luostarinen T; Namujju PB; Merikukka M; Dillner J; Hakulinen T; Koskela P; Paavonen J; Surcel HM; Lehtinen M Int J Cancer; 2013 Oct; 133(7):1756-9. PubMed ID: 23526412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]